Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| InfuSystem Holdings, IncINFU · Entity 6163 | 10% owner | December 07, 2020 | December 09, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
InfuSystem Holdings, Inc
Report date December 07, 2020 · Filed December 09, 2020
Jointly reported with BlueLine Capital Partners II, L.P., Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Partners, L.L.C.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 493,656 |
Last balance in matching sequence
After 2020-12-09 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2020-12-07 · Sale · Disposed 2,900 · Balance 499,850 F1: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Row 2 · 2020-12-08 · Sale · Disposed 4,489 · Balance 495,361 F1: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Row 3 · 2020-12-09 · Sale · Disposed 1,705 · Balance 493,656 F1: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 09, 2020 Filed Dec 9, 2020 17:40 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | SaleCommon Stock | 1,705 | $17.00 | $28,985.00 |
DisclosureSEC source: 0001096906-20-000461 · form4.xml · nonDerivative · entry 3 BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 493,656 F1 · ownership.direct: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 08, 2020 Filed Dec 9, 2020 17:40 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | SaleCommon Stock | 4,489 | $17.04 | $76,492.56 |
DisclosureSEC source: 0001096906-20-000461 · form4.xml · nonDerivative · entry 2 BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 495,361 F1 · ownership.direct: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 17:40 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | SaleCommon Stock | 2,900 | $17.21 | $49,909.00 |
DisclosureSEC source: 0001096906-20-000461 · form4.xml · nonDerivative · entry 1 BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 499,850 F1 · ownership.direct: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 18:09 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | OtherCommon Stock | 273,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001445866-20-001474 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 502,750 F2 · ownership.direct: These securities were owned by Meridian TSV II, LP. On September 30, 2020, Meridian TSV II, LP. executed an in-kind distribution, without consideration, of 273,457 of the Issuer's common stock to certain of its limited partners. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 18:09 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | OtherCommon Stock | 2,009,580 | $0.00 | $0.00 |
DisclosureSEC source: 0001445866-20-001474 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 776,207 F1 · ownership.direct: These securities were owned by Meridian OHC Partners, LP. On September 30, 2020, Meridian OHC Partners, LP executed an in-kind distribution, without consideration, of 2,009,580 of the Issuer's common stock to certain of its limited partners. Read SEC document |
| September 29, 2020 Filed Sep 30, 2020 18:04 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | SaleCommon Stock | 45,604 | $13.89 | $633,439.56 |
DisclosureSEC source: 0001445866-20-001428 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,740,183 F1 · ownership.direct: These securities were owned by Meridian OHC Partners, LP. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| September 28, 2020 Filed Sep 30, 2020 18:04 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | SaleCommon Stock | 37,300 | $13.93 | $519,589.00 |
DisclosureSEC source: 0001445866-20-001428 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,785,787 F1 · ownership.direct: These securities were owned by Meridian OHC Partners, LP. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 18:08 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | OtherCommon Stock | 16,801 | $0.00 | $0.00 |
DisclosureSEC source: 0001445866-20-000847 · form4.xml · nonDerivative · entry 1 BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,339,760 F1 · ownership.direct: These securities were owned by BlueLine Capital Partners II, LP. On June 11, 2020, BlueLine Capital Partners II, LP executed an in-kind distribution, without consideration, of 16,801 shares of the Issuer's common stock to certain of its limited partners. BlueLine Partners, LLC is the general partner of BlueLine Capital Partners II, LP, and Scott Shuda is managing director of BlueLine Partners, LLC. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, any Reporting Person is the beneficial owner of any Common Stock covered by this statement. Read SEC document |
| September 06, 2019 Filed Sep 6, 2019 20:42 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 2,000 | $5.05 | $10,100.00 |
DisclosureSEC source: 0001445866-19-001110 · form4.xml · nonDerivative · entry 3 Shuda Scott · CIK 0001486636 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Capital Partners, L.P. · CIK 0001338149 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,526,521 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. Read SEC document |
| September 05, 2019 Filed Sep 6, 2019 20:42 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 2,000 | $5.00 | $10,000.00 |
DisclosureSEC source: 0001445866-19-001110 · form4.xml · nonDerivative · entry 2 Shuda Scott · CIK 0001486636 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Capital Partners, L.P. · CIK 0001338149 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,524,521 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. Read SEC document |
| September 05, 2019 Filed Sep 6, 2019 20:42 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 1,004 | $4.90 | $4,919.60 |
DisclosureSEC source: 0001445866-19-001110 · form4.xml · nonDerivative · entry 1 Shuda Scott · CIK 0001486636 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Capital Partners, L.P. · CIK 0001338149 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,522,521 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.